Induction chemotherapy followed by radiotherapy and adjuvant chemotherapy for locally advanced nasopharyngeal carcinoma treated

Yun-sheng GAO,Hong-mei YING,Xiao-peng XIONG,Chao-su HU

DOI: https://doi.org/10.3760/j.issn:1004-4221.2007.04.001

2007-01-01

Abstract:Objective To summarize the efficacy and toxicities of induction chemotherapy followed by radiotherapy and adjuvant chemotherapy in the treatment of locally advanced nasopharyngeal carcinoma (NPC). Methods From Oct. 1997 to Nov. 2000, 77 patients with histologically proven locally advanced NPC, staged according to the Fuzhou stage classification, were retrospectively studied. Before radical radio- therapy, the patients received 1-3 cycles cisplatin (PDD) 20 mg/m~2 on Days 1-3 and fluorouracil (5-Fu) 500 mg/m~2 on Days 1-3 repeated every two weeks. Sixty-two patients also received calcium folinate(CF) 100 mg/m~2 on Days 1-3. Two to four cycles of adjuvant chemotherapy was given 21 days after the completion of radiotherapy. All patients received radical radiotherapy by ~(60) Co to the nasopharynx and neck with a total dose of 64-78 Gy at 1.8-2.0 Gy per fraction over 7.0-7.5 weeks to the primary site. The dose to the lymph nodes was 60-68 Gy. After-loading radiotherapy was given to the residual disease in 1 patient (20 Gy in 2 frac- tions). Results The median follow-up was 60 months (ranged from 3 to 103 months). The 5-year overall survival rate (OS), disease- free survival rate (DFS), relapse-free survival rate (RFS) and distant metas- tasis-free survival rate (DMSF) were 68%, 58%, 81% and 75%. The patients who received more than 3 cycles of chemotherapy or not had no significant effects on the OS (X~2=0.05, P=0.831). The incidence of grade 3 or 4 acute side-effects of radiotherapy was vomiting 1%, leukopenia 3%, mucositis 23% and skin reaction 5%, all of which eventually resolved. The most frequent late toxicities were hearing impairment (51%). Patients with more than 3 cycles chemotherapy were more likely to have late hearing loss (z= 2.06, P=0.039). Only one patient had radiation-induced brain damage. Conclusions Induction chemo- therapy, radiotherapy and adjuvant chemotherapy for locally advanced nasopharyngeal carcinoma would result in a comparable outcome, but may impair the hearing of patients.